Clinical Profile in Refractory Heart Failure and Its Outcome in Rural Institutional Setup
DOI:
https://doi.org/10.61841/9e7ra862Keywords:
-Refractory,, Heart Failure(HF),, Clinical profile, prognosisAbstract
Refractory HF can be defined as “the persistence of symptoms that limit daily life (functional class III or IV of the New York Heart Association [NYHA]) despite optimal previous treatment with drugs of proven efficacy for the condition.” This is very challenging to manage and so disease is associated with poor quality of life and high mortality rates. This study has been planned to see the clinical profile like etiology, clinical features and prognosis as studies regarding this in India is lacking.To study clinical profile of refractory heart failure in rural tertiary care hospital.To identify aetiology of refractory heart failure in rural population.To study the outcomes as duration of ICU stay, discharge and death.To compare the outcome in different gender and Body mass index status.In this cross sectional study, 40 patient were enrolled and diagnosed on the basis of criteria for refractory HF (European Society of Cardiology). Patient were admitted in Medicine department from October 2018 to January 2020.20(50%) patients had coronary artery disease, 18(45%) patients had cardiomyopathy, 22(55%) patients had acute or history of myocardial infarction. 6MWT was done in all patients (excluding patients who had contraindications). Total of 14(35%) patients had <300 meters walk on admission. 20(50%) patients had LVEF less than 20%. Total of 8(20%) patients had died in hospital.Refractory Heart Failure is associated with very high mortality rates. Hence screening the patient for etiology is very important. Early intervention and treatment of etiology can prevent further consequences of the disease.
Downloads
References
1. Hunt SA; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task
Force on Practice Guidelines (Writing Committee to update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005;46(6):e1–e82
2. Heart Failure Guidelines for India: Update 2017 Sandeep Seth, S. Ramakrishnan, Neeraj Parekh, G. Karthikeyan, Sandeep Singh, Gautam Sharma Department of Cardiology, All India Institute of Medical Sciences, New Delhi, India
3. Maestre, V.G., Gallego, J., García, M., García de Burgos, F. and Martín-Hidalgo, A. (2009) Prediction Clinical Profile to Distinguish between Systolic and Diastolic Heart Failure in Hospitalized Patients. European Journal of Internal Medicine, 20, 313-318. http://dx.doi.org/10.1016/j.ejim.2008.09.001
4. Aurigemma, G.P. and Gaasch, W.H. (2004) Diastolic Heart Failure. New England Journal of Medicine,
351, 1097- 1105. http://dx.doi.org/10.1056/NEJMcp022709
5. Reddy, S., Bahl, A. and Talwar, K. (2010) Congestive Heart Failure in Indians: How Do We Improve Diagnosis & Management? The Indian Journal of Medical Research, 132, 549
6. De Luca L, Fonarow GC, Adams KF Jr, Mebazaa A, Tavazzi L, Swedberg K, et al. Acute heart failure syndromes: clinical scenarios and pathophysiologic targets for therapy. Heart Fail Rev. 2007;12(2):97- 104.
7. Reis FJ, Fernandes AM, Bitencourt AG, Neves FB, Kuwano AY, França VH, et al. Prevalence of anemia and renal insufficiency in non-hospitalized patients with heart failure. Arq Bras Cardiol. 2009;93(3):268- 74.
8. Feola M, Lombardo E, Taglieri C, Piccolo S, Vado A. Plasma BNP and renal failure as prognostic factors of mid-term clinical outcome in congestive heart failure patients. Int J Cardiol. 2011;149(1):114-5.
9. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazneret MH, et al; American College of Cardiology Foundation.; American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary: a Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16):e147-e239
10. Nohria A, Lewis E, Stevenson LW. Medical management of advanced heart failure. JAMA 2002;287:628- 40.
11. Hunt S, Backer D, Chin M, Cinquegrani M, Feldman A, Francis G, et al. ACC/AHA Guidelines for the evaluation and management of chronic heart failure in the adult. J Am Coll Cardiol 2001;38:2101-13.
12. Acharya, Sourya, Samarth Shukla, and Anil Wanjari. “Subclinical Risk Markers for Cardiovascular Disease (CVD) in Metabolically Healthy Obese (MHO) Subjects.” JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH 13, no. 6 (June 2019): OC1–6.
https://doi.org/10.7860/JCDR/2019/41317.12890.
13. Acharya, Sourya, and Samarth Shukla. “Metabolic Healthy Obesity-A Paradoxical Fallacy?” JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH 12, no. 10 (October 2018): OE7–10.
https://doi.org/10.7860/JCDR/2018/36809.12165
14. Witte KK, Clark AL. Why does chronic heart failure cause breathlessness and fatigue? Prog Cardiovasc Dis. 2007;49:366 –384.
15. ATS statement: guidelines for the six-minute walk test. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. Am J Respir Crit Care Med. 2002;166:111–117.
16. V. Bittner, D. H. Weiner, S. Yusuf et al., “Prediction ofmortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction,” The Journal of the American Medical Association, vol. 270, no. 14, pp. 1702–1707, 1993
17. V. Bittner, D. H. Weiner, S. Yusuf et al., “Prediction ofmortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction,” The Journal of the American Medical Association, vol. 270, no. 14, pp. 1702–1707, 1993.
18. Ray, Kausik K., Helen M. Colhoun, Michael Szarek, Marie Baccara-Dinet, Deepak L. Bhatt, Vera A. Bittner, Andrzej J. Budaj, et al. “Effects of Alirocumab on Cardiovascular and Metabolic Outcomes after Acute Coronary Syndrome in Patients with or without Diabetes: A Prespecified Analysis of the ODYSSEY OUTCOMES Randomised Controlled Trial.” LANCET DIABETES & ENDOCRINOLOGY 7, no. 8 (August 2019): 618–28. https://doi.org/10.1016/S2213-8587(19)30158-5.
19. Mendez GF, Cowie MR. The epidemiological features of heart failure in developing countries: A review of the literature. Int J Cardiol. 2001; 80:213–19. [PubMed: 11578717]
20. World Health Organization. Global burden of disease—2004 update. Geneva: Switzerland: 2004.
21. Vakil RJ. A statistical study of 1281 cases of congestive cardiac failure or myocardial insufficiency in India. Indian Physician. 1949; 8:281–9. [PubMed: 18268798]
22. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, et al. Obesity and the risk of heart failure. N Engl J Med. 2002; 347:305–13. [PubMed: 12151467]
23. Reddy KS, Prabhakaran D, Shah P, Shah B. Differences in body mass index and waist: Hip ratios in North Indian rural and urban populations. Obes Rev. 2002; 3:197–202. [PubMed: 12164472]
24. World Health Organization. Geneva:Switzerland: The WHO Global InfoBase. Available at https://who.int/infobase [3 March 2010]
25. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al. HOT Study Group. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet. 1998; 351:1755–62. [PubMed: 9635947]
26. Neal B, MacMahon S, Chapman N. Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results HUFFMAN and PRABHAKARAN
27. Rodgers A, Ezzati M, Vander Hoorn S, Lopez AD, Lin RB, Murray CJ. Comparative risk assessment collaborating group distribution of major health risks: Findings from the global burden of disease study. PLoS Med. 2004; 1:e27. [PubMed: 15526049]
28. Thakur JS, Negi PC, Ahluwalia SK, Vaidya NK. Epidemiological survey of rheumatic heart disease among school children in the Shimla hills of northern India: Prevalence and risk factors. J Epidemiol Community Health. 1996; 50:62–7. [PubMed: 8762356]
29. Manyemba J, Mayosi BM. Penicillin for secondary prevention of rheumatic fever. Cochrane Database Syst Rev. 2002; 3 CD002227.
30. Xavier D, Pais P, Devereaux PJ, Xie C, Prabhakaran D, Reddy KS, et al. Treatment and outcomes of acute coronary syndromes in India (CREATE): A prospective analysis of registry data. Lancet. 2008; 371:1435–
42. [PubMed: 18440425]
31. Commission on Social Determinants of Health (CSDH). Closing the gap in a generation: Health equity through action on the social determinants of health. Final Report of the Commission on Social Determinants of Health. Geneva: WHO; 2008.
32. Harikrishnan S. Heart failure in India – Iceberg tsunami? J Pract Cardiovasc Sci 2016;2:2
33. Chaturvedi V, Parakh N, Seth S, Bhargava B, Ramakrishnan S, Roy A, et al. Heart failure in India: The Indus (India Ukieri Study) study. J Pract Cardiovasc Sci 2016;2:28.
34. Seth S, Khanal S, Ramakrishnan S, Gupta N, Bahl VK. Epidemiology of acute decompensated heart failure in India: The AFAR study (Acute failure registry study). J Pract Cardiovasc Sci 2015;1:35.
35. Docherla M, Hande MH, Kavitha S, Shastry BA, Bhatia S. Comparative study of systolic and diastolic cardiac failure in elderly hospitalized patients in a tertiary care hospital in Southwest India. J Clin Diagn Res 2009;3:1529‑36.
36. Harikrishnan S, Sanjay G, Anees T, Viswanathan S, Vijayaraghavan G, Bahuleyan CG, et al. Clinical
presentation, management, in‑hospital and 90‑day outcomes of heart failure patients in Trivandrum, Kerala, India: The Trivandrum heart failure registry. Eur J Heart Fail 2015;17:794‑800.
37. Jose VJ, Gupta SN. Mortality and morbidity of acute ST segment elevation myocardial infarction in the
current era. Indian Heart J 2004;56:210‑4.
38. Xavier D, Pais P, Devereaux PJ, Xie C, Prabhakaran D, Reddy KS,et al. Treatment and outcomes of acute coronary syndromes in India (CREATE): A prospective analysis of registry data. Lancet 2008;371:1435‑42.
39. Grover A, Dhawan A, Iyengar SD, Anand IS, Wahi PL, Ganguly NK. Epidemiology of rheumatic fever
and rheumatic heart disease in a rural community in Northern India. Bull World Health Organ 1993;71:59‑66.
40. Mehta SR, Yusuf S, Díaz R, Zhu J, Pais P, Xavier D, et al. Effect of glucose‑insulin‑potassium infusion on mortality in patients with acute ST‑segment elevation myocardial infarction: The CREATE‑ECLA randomized controlled trial. JAMA 2005;293:437‑46.
41. Holay MP, Janbandhu A, Javahirani A, Pandharipande MS, Suryawanshi SD. Clinical profile of acute myocardial infarction in elderly (prospective study). J Assoc Physicians India 2007;55:188‑92.
42. Prabhakaran D, Yusuf S, Mehta S, Pogue J, Avezum A, Budaj A, et al. Two‑year outcomes in patients admitted with non‑ST elevation acute coronary syndrome: Results of the OASIS registry 1 and 2. Indian Heart J 2005;57:217‑25.
43. Charan N, Choudhari M, Sonkusale M, Deshpande R. Anesthetic management of chronic thromboembolic pulmonary hypertension for pulmonary endarterectomy. J Datta Meghe Inst Med Sci Univ 2017;12(4):289-291.
44. Kashikar SV. Congenital unilateral infiltrating facial lipomatosis. West Indian Med J 2017;66(1):189-190.
45. Kumar G, Phatak SV, Lakhkar B, Yadaw SK. Diagnostic role of magnetic resonance imaging in rotator cuff pathologies. J Datta Meghe Inst Med Sci Univ 2017;12(1):7-10.
46. Tidake P, Sharma S. Profile and management of primary open-angle glaucoma patients above 40 years: A rural hospital-based study. J Datta Meghe Inst Med Sci Univ 2017;12(1):1-6.
47. Bhriegu R, Agrawal M, Hariharan C. Assessment of maternal and perinatal outcome in postdated pregnancy. J Datta Meghe Inst Med Sci Univ 2017;12(1):35-40.
48. Priya N, Lamture YR, Luthra L. A comparative study of scalpel versus surgical diathermy skin incisions in clean and clean-contaminated effective abdominal surgeries in AVBRH, Wardha, Maharashtra, India. J Datta Meghe Inst Med Sci Univ 2017;12(1):21-25.
49. Jaipuriya P, Pate MY, Iratwar S, Mahakalkar CC, Chandankhede A. Clinical study, evaluation, and management of cases of intracranial tumors admitted at Acharya Vinoba Bhave rural hospital, Sawangi (Meghe). J Datta Meghe Inst Med Sci Univ 2017;12(1):26-31.
50. Gupta M, Samal S, Shrivastava D, Bagde N, Mishra N, Gupta S. The study of ovulatory pattern following use of clomiphene citrate and anastrozole in infertile women with ovulatory dysfunction: A comparative study. J Datta Meghe Inst Med Sci Univ 2017;12(1):17-20.
51. Gupta K, Mahakalkar C, Kaple M, Deshpande S, Ladhha P, Jain N. A comparative study of cilostazol and pentoxifylline in intermittent claudication in peripheral arterial disease. J Datta Meghe Inst Med Sci Univ 2017;12(1):11-16.
52. Swarnkar M, Agrawal A. Kimura’s disease: A case report and review of literature. J Krishna Inst Med Sci Univ 2017;6(3):118-120.
53. Swarnkar M, Jain SC. Web space lipoma causing separation of toes - a rare case report with review of literature. J Krishna Inst Med Sci Univ 2017;6(2):107-110.
54. Tendulkar MP, Ninave SS. Prospective comparison of pressor and airway responses to IV esmolol and IV dexmedetomidine during emergence from general anaesthesia and extubation. J Krishna Inst Med Sci Univ 2017;6(1):49-56.
55. Taksande AB, Jagzape AT, Deshpande VK. Study of motor nerve conduction velocity in patients of thyroid dysfunction in central India. J Datta Meghe Inst Med Sci Univ 2017;12(4):229-233.
56. Majumdar MR, Sune MP, Mohod P. Helmet-induced ocular trauma: A rare mechanism. J Datta Meghe Inst Med Sci Univ 2017;12(4):292-293.
57. Bhattacharjee J, Jogdand S, Goswami S, Shinde R, Padhye MR. Evaluation of analgesic activity of simvastatin and atorvastatin in Wistar rats: An experimental study. Natl J Physiol Pharm Pharmacol 2017;7(10):1031-1035.
58. Gade SA, Chari SN, Chalak A. Use of mini-CEX as a teaching learning method in physiology for undergraduate medical students. Natl J Physiol Pharm Pharmacol 2017;7(5):482-485.
59. Garg S, Chakravarti A, Singh R, Masthi NRR, Goyal RC, Jammy GR, et al. Dengue serotype-specific seroprevalence among 5- to 10-year-old children in India: a community-based cross-sectional study. Int J Infect Dis 2017;54:25-30.
60. Jagzape AT, Jagzape T, Rawekar A. Patient-based integrated teaching program with the inclusion of psychomotor and affective domains. Natl J Physiol Pharm Pharmacol 2017;7(8):788-792.
61. Tendolkar VD, Behere P, Quazi Z, Gaidhane A. Heterogeneous group discussion to improve reliability and validity of data tool: A global mental health assessment tool – primary care version study. J Datta Meghe Inst Med Sci Univ 2017;12(1):45-50.
62. Yunati MS, Deshpande V, Yuwanate AH, Sorte SR, Sirsam SS. Sahaja yoga meditation as a tool to enhance aging pulmonary functions. Natl J Physiol Pharm Pharmacol 2017;7(3):333-338.
63. Behere PB, Kumar K, Behere AP. Depression: Why to talk? Indian J Med Res 2017;145(April):411-413.
64. Gupta R, Das S, Gujar K, Mishra K, Gaur N, Majid A. Clinical Practice Guidelines for Sleep Disorders. Indian J Psychiatry 2017;59(5):S116-S138.
65. Khatib MN, Gaidhane A, Gaidhane S, Quazi ZS. Ghrelin as a promising therapeutic option for cancer cachexia. Cell Physiol Biochem 2018;48(5):2172-2188.
66. Gaidhane A, Sinha A, Khatib M, Simkhada P, Behere P, Saxena D, et al. A systematic review on effect of electronic media on diet, exercise, and sexual activity among adolescents. Indian J Community Med 2018;43(5):S56-S65.
67. Khatib M, Sinha A, Gaidhane A, Simkhada P, Behere P, Saxena D, et al. A systematic review on effect of electronic media among children and adolescents on substance abuse. Indian J Community Med 2018;43(5):S66-S72.
68. Khatib MN, Kirubakaran R, Gaidhane S, Shankar AH, Quazi Syed Z. Yoga for improving functional capacity, quality of life and cardiovascular outcomes in people with heart failure. Cochrane Database Syst Rev 2017;2017(7).
69. Uddin S, Mahmood H, Senarath U, Zahiruddin Q, Karn S, Rasheed S, et al. Analysis of stakeholders networks of infant and young child nutrition programmes in Sri Lanka, India, Nepal, Bangladesh and Pakistan. BMC Public Health 2017;17.
70. Puri S, Fernandez S, Puranik A, Anand D, Gaidhane A, Quazi Syed Z, et al. Policy content and stakeholder network analysis for infant and young child feeding in India. BMC Public Health 2017;17.
71. Tendolkar VD, Behere P, Quazi Z, Gaidhane A. Heterogeneous group discussion to improve reliability and validity of data tool: A global mental health assessment tool – primary care version study. J Datta Meghe Inst Med Sci Univ 2017;12(1):45-50.
72. Balwani MR, Bawankule C, Khetan P, Ramteke V, Tolani P, Kute V. An uncommon cause of rapidly progressive renal failure in a lupus patient: Pauci-immune crescentic glomerulonephritis. Saudi J Kidney Dis Transpl 2018;29(4):989-992.
73. Mohite D, Hande A, Gupta R, Chaudhary M, Mohite P, Patil S, et al. Immunohistochemical evaluation of expression pattern of p53, p63, and p73 in epithelial dysplasia. J Datta Meghe Inst Med Sci Univ 2018;13(3):122-129.
74. Rathi N, Chandak M, Mude G. Comparative evaluation of dentinal caries in restored cavity prepared by galvanic and sintered burs. Contemp Clin Dent 2018;9(5):S23-S27.
75. Gupta V, Bhake A. Reactive Lymphoid Hyperplasia or Tubercular Lymphadenitis: Can Real-Time PCR on Fine-Needle Aspirates Help Physicians in Concluding the Diagnosis? Acta Cytol 2018;62(3):204-208.
76. Zodpey S, Sharma A, Zahiruddin QS, Gaidhane A, Shrikhande S. Allopathic Doctors in India: Estimates, Norms and Projections. J Health Manage 2018;20(2):151-163.
77. Yadav S, Agrawal M, Hariharan C, Dewani D, Vadera K, Krishna N. A comparative study of serum lipid profile of women with preeclampsia and normotensive pregnancy. J Datta Meghe Inst Med Sci Univ 2018;13(2):83-86.
78. Bhinder HHPS, Kamble TK. The study of carotid intima-media thickness in prediabetes and its correlation with cardiovascular risk factors. J Datta Meghe Inst Med Sci Univ 2018;13(2):79-82.
79. Munjal R, Mudey G. Nasal carriage of Staphylococcus aureus among undergraduate medical students: Prevalence and antibiogram including methicillin resistance, inducible clindamycin resistance, and high- level mupirocin resistance. J Datta Meghe Inst Med Sci Univ 2018;13(2):91-94.
80. Mittal V, Jagzape T, Sachdeva P. Care seeking behaviour of families for their sick infants and factors impeding to their early care seeking in rural part of central India. J Clin Diagn Res 2018;12(4):SC08- SC12.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
